Mankind Pharma Limited

Mankind Pharma Limited

Performance

Today's Low Today's High
2,462.15 2,464.00
2,549.00 2547.90
52 Week Low 52 Week High
1,683.05 (01-Nov-2023) 1,685.00 (01-Nov-2023)
2,564.95 (13-Sep-2024) 2,563.95 (13-Sep-2024)

Open
2,490.95 2,480.00
Previous Close
2,426.05 2,431.00
Volume
1.96
Total Traded value
49.36 (₹ Lakhs)
Upper circuit
2,911.25 2,443.10
Lower circuit
1,940.85 1,998.90

Market Depth

Buy Order Quantity Sell Order Quantity
34,882
38,895

Bid PriceQuantity
2,541.6037.00
2,541.351,326.00
2,541.3084.00
2,541.2510.00
2,541.10133.00
Total:34,882
Ask PriceQuantity
2,542.0034.00
2,542.4014.00
2,542.752.00
2,542.802.00
2,542.902.00
Total:38,895

Fundamentals

Market Cap: ₹1,018.18 Cr
PE Ratio (TTM): 50.53
PB Ratio: 10.12
Industry P/E:49.18
Debt to Equity:0.00
ROE:20.03
EPS (TTM):48.11
Book Value:23.69
Face Value: 1.00

Financials

Mar, 2023Jun, 2023Mar, 2023Sep, 2023Sep, 2023
Revenue19.80 Cr10.40 Cr1,872.12 Cr2,453.35 Cr2,453.35 Cr
Profit3.30 Cr0.84 Cr280.99 Cr472.88 Cr472.88 Cr
Expense15.63 Cr9.27 Cr1,559.14 Cr1,899.50 Cr1,899.50 Cr
Comprehensive income3.34 Cr0.84 Cr284.69 Cr469.33 Cr469.33 Cr
EPS2.810.727.0111.7911.79
Mankind Pharma Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of pharmaceutical formulations and consumer healthcare products. With a strong presence in India and international markets, the company focuses on creating pharmaceuticals for acute and chronic therapeutics in various areas including anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases.

In addition to pharmaceuticals, Mankind Pharma also offers a range of consumer healthcare products such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. These products are marketed under well-known brand names like Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar.

Apart from its core business, Mankind Pharma is involved in trading and exporting pharmaceutical and healthcare products. The company also engages in the manufacturing of packing materials, ayurvedic products, bulk drugs, and consumer goods. Furthermore, it has diversified into real estate, leasing, and hospitality businesses, as well as providing IT services.

Established in 1986 and headquartered in New Delhi, India, Mankind Pharma Limited has grown to become a trusted name in the pharmaceutical industry, committed to improving healthcare and enhancing the well-being of individuals worldwide.
Company nameListing dateIndustry NSE symbol BSE symbol
Mankind Pharma Limited May, 2023 May, 2023 Pharmaceuticals Pharmaceuticals MANKIND MANKIND

Shareholding pattern

Sep, 2023 Jun, 2023 May, 2023

  • Promoters 
    76.50%
    Public 
    23.50%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    76.50%
    Public 
    23.50%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    76.50%
    Public 
    23.50%
    Shares held by Employee Trusts 
    0.00%

Mankind Pharma Limited FAQ's

What is the range of today's stock performance for Mankind Pharma Limited?

Today's stock performance witnessed a fluctuation from a minimum of 2,462.15 on the NSE (National Stock Exchange) to a maximum of 2,549.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 2,464.00 to a high of 2,547.90.

What are the 52-week low and high values for Mankind Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 1,683.05 (occurred on 01-Nov-2023) and a high of 2,564.95 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,685.00 (on 01-Nov-2023), and the 52-week high is 2,563.95 (on 13-Sep-2024).

What was the opening and previous closing prices for Mankind Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 1,683.05 (occurred on 01-Nov-2023) and a high of 2,564.95 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,685.00 (on 01-Nov-2023), and the 52-week high is 2,563.95 (on 13-Sep-2024).

What is the total volume and traded value for Mankind Pharma Limited for the day?

The total volume is 2, and the total traded value is 49.36 (₹ Lakhs).

What are the upper and lower circuit limits for Mankind Pharma Limited?

The upper circuit limit is 2,911.25, and the lower circuit limit is 1,940.85.

What is the market cap and PE ratio for Mankind Pharma Limited?

The market cap is ₹1,018.18 Cr, and the PE ratio (TTM) is 49.18.

What is the PB ratio, industry P/E, and debt to equity ratio for Mankind Pharma Limited?

The PB ratio is 106.71, industry P/E is 49.18 , and the debt to equity ratio is 0.00.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Mankind Pharma Limited?

ROE is 20.03, EPS is 48.11, book value is 23.69

What are the revenue and profit figures for the latest quarter and previous quarters for Mankind Pharma Limited?

In Mar 2023, Revenue is ₹198032000.00, and Profit is ₹32993000.00. In Jun 2023, Revenue is ₹104040000.00, and Profit is ₹8407000.00.

When was Mankind Pharma Limited listed, and what industry does it belong to?

The company, Mankind Pharma Limited, was listed in May 2023 and belongs to the Pharmaceuticals industry. Its NSE symbol is MANKIND.

What is the current shareholding pattern of the Mankind Pharma Limited?

As of latest available update, promoters hold 76.50%, the public holds 23.50%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
1872
Threads
33
Settings

Latest Business News

Back
Top